A computer-aided procedure automating the identification of illicit amphetamine analogs eluting from a gas chromatograph coupled to a Fourier transform infrared spectrometer is presented. The expert system discriminates novel amphetamines from other classes of drugs of abuse normally screened in illicit tablets or powders. The main analytical advantages of the system over the automated procedures dedicated to general unknown analysis are the objectivity and the accuracy in predicting the class identity of the compound (i.e. stimulant, hallucinogen) when the reference spectrum is not present in the spectral library. The expert system uses quantitative thresholds defining the similarity of the unknown to the classes of illicit amphetamines and checks the presence of the molecular skeletons associated with different psychotropic effects of amphetamines. The challenge in building the system was the fuzziness of vapor-phase Fourier transform infrared spectrometer spectra of low-weight molecules such as amphetamines. This paper emphasizes the chemometrical techniques found most appropriate for modeling such spectral behavior. An exploratory (principal component) analysis indicated the sample preparation and the feature weight function yielding the best input for the knowledge base. The class identity of a compound was assigned using Soft Independent Modeling of Class Analogy. A rule-based decision system was implemented to enhance the accuracy in identity assignment. The flow diagram optimizing the knowledge base content of each model is presented. Finally, up to 81.13% (out of 159 tested compounds) were classified with a 5% confidence level. The total correct classification rate was 93.93%, for a yield of 96.30% true positive amphetamines.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0039-9140(00)00461-6 | DOI Listing |
Addiction
January 2025
Centre for Clinical Research in Emergency Medicine, Harry Perkins Institute of Medical Research, Perth, Australia.
Aims: This study aimed to describe clinical features and outcomes of patients presenting to the emergency department with analytically confirmed methamphetamine intoxication, to determine the blood concentration of methamphetamine and to test its association with clinical findings.
Design: The Western Australian Illicit Substance Evaluation (WISE) study is a prospective observational cohort study.
Setting: Royal Perth Hospital Emergency Department, Perth, Australia, between 2016 and 2018.
Molecules
December 2024
Valladolid University Foundation, Valladolid University, Paseo de Belén, 11, 47011 Valladolid, Spain.
The emergence of new psychoactive substances (NPS) in the global drug market since the 2000s has posed major challenges for regulators and law enforcement agencies. Among these, synthetic cathinones have gained prominence due to their stimulant effects on the central nervous system, leading to widespread recreational use. These compounds, often marketed as alternatives to illicit stimulants such as amphetamines and cocaine, have been linked to numerous cases of intoxication, addiction and death.
View Article and Find Full Text PDFSci Rep
January 2025
Golestan Research Center of Gastroentrology and Hepatology & Stem Cell Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Children are highly sensitive to toxins which can damage their organs and lead to death. Investigating the main causes of intoxication could reduce mortality and morbidity in children. In this cross-sectional study, the documents of all poisoned patients (214 cases) admitted to the emergency department of Taleghani children`s Hospital between April 2020 and 2023 were investigated.
View Article and Find Full Text PDFFuture Med Chem
January 2025
Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Methamphetamine (METH) is a highly addictive illicit psychostimulant with a significant annual fatality rate. Emerging studies highlight its role in neuroinflammation and a range of neurological disorders. This review examines the current landscape of potential drug targets for managing neuroinflammation in METH use disorders (MUDs), with a particular focus on the rationale behind targeting Toll-like receptor 4 (TLR4), the NLR family pyrin domain containing 3 (NLRP3) inflammasome, and other promising targets.
View Article and Find Full Text PDFJAACAP Open
December 2024
Deakin University, Geelong, Australia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!